| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:1536.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
From the Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC (T.W., C.D., S.S.V., P.J.G.C.); Dorothy M. Davis Heart and Lung Research Institute, Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio (E.E.H., N.I.M., R.E.M.); Genetic Therapy, Inc, Gaithersburg, Md (S.C.S., J.M.N.); and the Transplantation Department, Novartis, Basel, Switzerland (N.R.M.).
Correspondence to Dr Pascal J. Goldschmidt-Clermont, Department of Medicine, Duke University Medical Center, Box 3845, Durham NC 27710. E-mail golds017{at}mc.duke.edu
Background The killing of vascular cells by activated macrophages is an important step in the process of destabilization of the arterial wall. The death receptor Fas is implicated in vascular cell death. Hence, we extended our studies in a rat aortic allograft model, using adenovirus-mediated overexpression of soluble Fas (sFas) to block Fas binding to Fas ligand (Fas-L). The contribution of Fas to vascular cell injury and consequent transplant arteriosclerosis was investigated.
Methods and Results Activated monocytes in the presence of macrophage colony-stimulating factor induce endothelial cell apoptosis in vitro, which was significantly inhibited by adenovirus-mediated sFas overexpression. Next, donor rat abdominal aortas were either untreated or transduced with adenoviruses encoding (1) rat soluble Fas (Ad3rsFas), (2) no insert (Ad3Null), and (3) ß-galactosidase (Ad3nBg). A total of 175 aortic grafts were harvested 2 to 90 days after transplantation. Vascular cell apoptosis and CD45+ cell infiltration were significantly reduced in Ad3rsFas-transduced aortas, as compared with control allografts. Moreover, the control allografts developed marked intimal thickening, whereas Ad3rsFas-transduced allografts had significantly less neointima until the 90-day time point.
Conclusions sFas overexpression protects the integrity of the vessel wall from immune injury and attenuates transplant arteriosclerosis.
Key Words: arteriosclerosis apoptosis endothelium inflammation gene therapy
This article has been cited by other articles:
![]() |
T. Q. Nhan, W. C. Liles, and S. M. Schwartz Role of Caspases in Death and Survival of the Plaque Macrophage Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 895 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Choy, A. Kerjner, B. W. Wong, B. M. McManus, and D. J. Granville Perforin Mediates Endothelial Cell Death and Resultant Transplant Vascular Disease in Cardiac Allografts Am. J. Pathol., July 1, 2004; 165(1): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Kokkonen, M. T. Augustin, J. M. Makinen, J. Kokkonen, and T. J. Karttunen High Endothelial Venules of the Lymph Nodes Express Fas Ligand J. Histochem. Cytochem., May 1, 2004; 52(5): 693 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
H J Ankersmit, T Weber, J Auer, G Roth, M Brunner, E Kvas, B Moser, S Spreitzer, E Lassnig, E Maurer, et al. Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina Heart, February 1, 2004; 90(2): 151 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vassalli, S. Fleury, J. Li, J.-J. Goy, L. Kappenberger, and L. K. von Segesser Gene transfer of cytoprotective and immunomodulatory molecules for prevention of cardiac allograft rejection Eur. J. Cardiothorac. Surg., November 1, 2003; 24(5): 794 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S Vasudevan, N. H.M Lopes, P. N Seshiah, T. Wang, C. B Marsh, D. J Kereiakes, C. Dong, and P. J Goldschmidt-Clermont Mac-1 and Fas activities are concurrently required for execution of smooth muscle cell death by M-CSF-stimulated macrophages Cardiovasc Res, September 1, 2003; 59(3): 723 - 733. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |